TopBP1 assembles nuclear condensates to switch on ATR signaling.


Journal

Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571

Informations de publication

Date de publication:
18 03 2021
Historique:
received: 02 07 2019
revised: 01 10 2020
accepted: 16 12 2020
pubmed: 28 1 2021
medline: 2 4 2021
entrez: 27 1 2021
Statut: ppublish

Résumé

ATR checkpoint signaling is crucial for cellular responses to DNA replication impediments. Using an optogenetic platform, we show that TopBP1, the main activator of ATR, self-assembles extensively to yield micrometer-sized condensates. These opto-TopBP1 condensates are functional entities organized in tightly packed clusters of spherical nano-particles. TopBP1 condensates are reversible, occasionally fuse, and co-localize with TopBP1 partner proteins. We provide evidence that TopBP1 condensation is a molecular switch that amplifies ATR activity to phosphorylate checkpoint kinase 1 (Chk1) and slow down replication forks. Single amino acid substitutions of key residues in the intrinsically disordered ATR activation domain disrupt TopBP1 condensation and consequently ATR/Chk1 signaling. In physiologic salt concentration and pH, purified TopBP1 undergoes liquid-liquid phase separation in vitro. We propose that the actuation mechanism of ATR signaling is the assembly of TopBP1 condensates driven by highly regulated multivalent and cooperative interactions.

Identifiants

pubmed: 33503405
pii: S1097-2765(20)30991-6
doi: 10.1016/j.molcel.2020.12.049
pii:
doi:

Substances chimiques

Carrier Proteins 0
DNA-Binding Proteins 0
Nuclear Proteins 0
TOPBP1 protein, human 0
ATR protein, human EC 2.7.11.1
Ataxia Telangiectasia Mutated Proteins EC 2.7.11.1
CHEK1 protein, human EC 2.7.11.1
Checkpoint Kinase 1 EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1231-1245.e8

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Auteurs

Camilla Frattini (C)

Institut de Génétique Humaine, CNRS, Université de Montpellier, Montpellier, France.

Alexy Promonet (A)

Institut de Génétique Humaine, CNRS, Université de Montpellier, Montpellier, France.

Emile Alghoul (E)

Institut de Génétique Humaine, CNRS, Université de Montpellier, Montpellier, France.

Sophie Vidal-Eychenie (S)

Institut de Génétique Humaine, CNRS, Université de Montpellier, Montpellier, France.

Marie Lamarque (M)

Institut de Génétique Humaine, CNRS, Université de Montpellier, Montpellier, France.

Marie-Pierre Blanchard (MP)

Institut de Génétique Humaine, CNRS, Université de Montpellier, Montpellier, France.

Serge Urbach (S)

Institut de Génomique Fonctionnelle, CNRS INSERM, Université de Montpellier, Montpellier, France.

Jihane Basbous (J)

Institut de Génétique Humaine, CNRS, Université de Montpellier, Montpellier, France. Electronic address: jihane.basbous@igh.cnrs.fr.

Angelos Constantinou (A)

Institut de Génétique Humaine, CNRS, Université de Montpellier, Montpellier, France. Electronic address: angelos.constantinou@igh.cnrs.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH